Four proteins previously reported in the literature as regulated in ALS were selected for validation: Galectin-3 (LGALS3), prealbumin (TTR), Protein S100-A11 (S100A11) and Protein S100-A6 (S100A6). The gene discussed is LGALS3; the disease is amyotrophic lateral sclerosis.